Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Saint Vincents Hospital Sydney, Darlinghurst

Blacktown Cancer and Haematology Centre, Blacktown

Austin Health, Heidelberg

Monash Health, Clayton

Gallipoli Medical Research Foundation, Greenslopes

Pindara Private Hospital, Benowa

Royal Adelaide Hospital, Adelaide

Perth Blood Institute, West Perth

Beijing Cancer Hospital, Beijing

The First Hospital of Jilin University, Changchun

Fudan University Shanghai Cancer Center, Shanghai

Affiliated Zhongshan Hospital of Fudan University, Shanghai

The First Affiliated Hospital of Soochow University, Suzhou

Jining No Peoples Hospital West Branch, Jining

Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

Fujian Cancer Hospital, Fuzhou

The Third Xiangya Hospital of Central South University, Changsha

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Hubei Cancer Hospital, Wuhan

Henan Cancer Hospital, Zhengzhou

Peking University Shenzhen Hospital, Shenzhen

West China Hospital, Sichuan University, Chengdu

General Hospital of Ningxia Medical University, Yinchuan